In a recent development, the LGT Group Foundation has sold 150,737 shares of Freeport-McMoRan Inc., reducing its ownership to 87%. This move comes as Freeport-McMoRan Inc....
Investment firm Machina Capital S.A.S. has increased its position in Freeport-McMoRan Inc., a leading mining company....
FREEPORT-MCMORAN INC. has recently seen a significant achievement in hitting the price target forecast provided by QuantWave, resulting in a profit of 21.39% for investors....
On May 23, 2025, QuantWave, an automated forecasting platform, released a prediction signal for Freeport-McMoRan Inc. (FCX) with a long direction at a price of 38.89 $....
FREEPORT-MCMORAN INC. has successfully reached the price target forecasted by QuantWave, resulting in a profit gain of 19.1%. The forecast signal was issued on May 27, 2025, with a price of 39.51 $....
FREEPORT-MCMORAN INC. has successfully reached the price target forecast issued by QuantWave, resulting in a significant profit of 18.58%....
On May 20, 2025, QuantWave issued a long signal for Freeport-McMoRan Inc. (NYSE: FCX) at a price of $38.27....
QuantWave's forecast signal for FREEPORT-MCMORAN INC. on May 16, 2025, proved to be accurate as the stock reached the predicted target on July 8, 2025....
FREEPORT-MCMORAN INC. (FCX) investors recently saw a successful forecast play out as QuantWave's prediction hit a price target with a 19.25% profit margin....
FREEPORT-MCMORAN INC. has successfully reached the price target forecasted by QuantWave, resulting in a profit of 21.73%. The forecast signal was generated on May 21, 2025, with a price of 37.89 $....
Biogen Inc., a leading biotechnology company, is facing a setback as Stifel downgrades its stock due to uncertainty surrounding the launch of its Alzheimer's drug....
Biogen Inc., a leading biotechnology company, has been in the spotlight recently due to its underperformance in the healthcare sector....
CF Industries Holdings Inc., a global leader in nitrogen fertilizers production, is experiencing a decline in stock performance compared to the Dow Jones Industrial Average....
Eli Lilly and Company, a global pharmaceutical giant, experienced a significant drop in its stock value following the release of its Q3 earnings report....
Biogen Inc. (NASDAQ: BIIB) has been experiencing underperformance in the healthcare sector, raising concerns among investors....